Any feedback?
Literature summary for 2.3.2.17 extracted from
- FemA of Staphylococcus aureus: isolation and immunodetection (1995), FEMS Microbiol. Lett., 132, 221-228.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | in 40 methicillin-susceptible and 6 resistant clinical isolates of Staphylococcus aureus, the FemA content or its affinity to the antibodies is reduced compared to laboratory parent strains. In susceptible strains, an additional protein of higher molecular weight, present in large quantities, is also able to bind the FemA antibodies. Such a protein is also present in methicillin-resistant isolates, although it is not as pronounced as in the susceptible strains | Staphylococcus aureus |
Localization
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| cytoplasm | - |
Staphylococcus aureus | 5737 | - |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Staphylococcus aureus | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| FemA | - |
Staphylococcus aureus |
General Information
| General Information | Comment | Organism |
|---|---|---|
| metabolism | all investigated strains, either methicillin-resistant or susceptible, express FemA during the exponential growth phase in varying amounts. In the stationary phase, the FemA content is diminished. Strains in which FemA is inactivated by insertion of Tn551 into the control region of the FemAB operon still express about 10% of the protein compared to their parent strains. Tn551 insertion in the middle of the femB gene does not affect the FemA expression | Staphylococcus aureus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
